 CINCINNATI, OH ACCESSWIRE September 1, 2021 Meridian Bioscience, Inc. NASDAQ:VIVO, a provider of diagnostic testing solutions and life science raw materials, today announced its wholly owned subsidiary, Magellan Diagnostics, Inc. Magellan, expanded the Class I recall of its LeadCare II Blood Lead Test Kits, LeadCare Plus Blood Lead Test Kits, and LeadCare Ultra Blood Lead Test Kits the LeadCare Test Kits for the detection of lead in whole blood. Magellan provides two controls in the test kits which are designed to mimic blood and are spiked with lead to specific target values with an associated acceptable range. 